Lilly launches the Lilly Change the Course Commitment, aiming to address treatment gaps in diabetes and obesity in LMICs

Summary

Eli Lilly launched the Lilly Change the Course Commitment to expand access to its diabetes and obesity medicines in low- and middle-income countries, with a goal to reach as many patients in resource-limited settings as in high-income countries by 2040.